Competing interests
MM
SL received institutional research grants from Bristol-Myers Squibb and Lilly and serves as an advisory board member for Merck, Bristol-Myers Squibb, Merck Sharp and Dohme, Servier, Sanofi and Amgen. MS is an advisory board member for Bristol-Myers Squibb, Lilly, MSD and is a speaker for Bristol-Myers Squibb, Lilly, MSD and Roche. MM received institutional research grants from Bristol-Myers Squibb, Merck, MSD and Amgen and serves as an advisory board member and speaker for Bristol-Myers Squibb, Merck Sharp and Dohme, Servier, Sanofi, Amgen, Lilly, Pfizer and Taiho. All the other authors declare no competing interests.